By the numbers for 2018: The top 100 venture players in biotech — and who's been paying the piper in cancer R&D?
The explosion of oncology R&D over the past few years has had a dramatic impact on a variety of fronts, all clearly illustrated in these lineups of the top 100 venture investors in biotech from Chris Dokomajilar at DealForma.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.